Cargando…
How do we best relax control measures as vaccine coverage for SARS-CoV-2 rises?
Autores principales: | Foy, Brody H, Wahl, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447897/ https://www.ncbi.nlm.nih.gov/pubmed/34549201 http://dx.doi.org/10.1016/j.lanwpc.2021.100271 |
Ejemplares similares
-
How Can We Best Use COVID-19 Vaccines in Adolescents? An International Perspective
por: Zhong, Youjia, et al.
Publicado: (2021) -
How Did We Get Here: The Best Vaccines Ever Facing the Highest Public Hesitancy?
por: Ferreccio, Catterina
Publicado: (2023) -
SARS-CoV-2 immunogenicity: Is S protein the best target for vaccination?
por: Antonopoulou, Tania, et al.
Publicado: (2022) -
How Can We Best Use COVID-19 Vaccines in Adolescents? A Perspective From the United States
por: Tyungu, Donna L., et al.
Publicado: (2021) -
Glucocorticoids: do we know how they work?
por: Saklatvala, Jeremy
Publicado: (2002)